Ethics. Research. Community.

With Short Outbreaks and Complex Permissions, Testing Critical Ebola Treatments is a Challenge

There are now several experimental treatments vying to be tested, but each must be greenlit by national regulatory authorities whenever and wherever an outbreak occurs. There remain deeply divergent positions among scientists about how to design outbreak trials, specifically whether studies that don’t compare treatments to placebos can generate useful data

Login or register to tag items